Qtron Investments LLC Regeneron Pharmaceuticals, Inc. Transaction History
Qtron Investments LLC
- $693 Million
- Q4 2024
A detailed history of Qtron Investments LLC transactions in Regeneron Pharmaceuticals, Inc. stock. As of the latest transaction made, Qtron Investments LLC holds 1,415 shares of REGN stock, worth $954,092. This represents 0.15% of its overall portfolio holdings.
Number of Shares
1,415
Previous 1,415
-0.0%
Holding current value
$954,092
Previous $1.49 Million
32.28%
% of portfolio
0.15%
Previous 0.21%
Shares
10 transactions
Others Institutions Holding REGN
# of Institutions
1,487Shares Held
83.4MCall Options Held
1.32MPut Options Held
1.52M-
Vanguard Group Inc Valley Forge, PA9.29MShares$6.26 Billion0.12% of portfolio
-
Black Rock Inc. New York, NY8.45MShares$5.7 Billion0.2% of portfolio
-
Jpmorgan Chase & CO New York, NY7.06MShares$4.76 Billion0.41% of portfolio
-
State Street Corp Boston, MA4.9MShares$3.31 Billion0.21% of portfolio
-
Capital International Investors Los Angeles, CA4.74MShares$3.19 Billion0.66% of portfolio
About REGENERON PHARMACEUTICALS, INC.
- Ticker REGN
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 107,190,000
- Market Cap $72.3B
- Description
- Regeneron Pharmaceuticals, Inc. discovers, invents, develops, manufactures, and commercializes medicines for treating various diseases worldwide. The company's products include EYLEA injection to treat wet age-related macular degeneration and diabetic macular edema; myopic choroidal neovascularization; and diabetic retinopathy, as well as macula...